COO Scott Lish of Alphatec Holdings sold 19,900 shares for $390,836 on Dec. 16, 2025, reducing direct ownership to 0.43% of shares outstanding. The sale was in direct holdings only, reflecting a consistent approach as share capacity declines. Alphatec Holdings is a U.S.-based medical technology company specializing in spinal surgery systems, with revenue of $728.02 million and a 127.08% 1-year price change. The recent sale by Lish does not raise concerns and comes amidst an upswing in Alphatec stock. Investors can consider Alphatec as a solid medical technology investment option.

Read more at Nasdaq: Is Alphatec Stock a Buy or Sell After Its COO Dumped Nearly 20,000 Shares?